Bliss GVS Pharma

Bliss GVS Pharma will boost profits with 12.79% margin surge

SNKRRMGM

Invested

Community Contributor

Published

09 Aug 25

Updated

09 Aug 25

SNKRRMGM's Fair Value

₹165.84

2.7% undervalued

09 Aug

₹161.30

23.4%

-7.6%

Author's Valuation

₹165.8

2.7% undervalued

SNKRRMGM's Fair Value

Narrative

Updates0

SNKRRMGM'sFair Value

₹165.8

2.7% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

0.00%

Pharma revenue growth rate

0.58%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

12.73%

Calculation

₹1.85b

Earnings '30

17.57x

PE Ratio '30

₹32.49b

Market Cap '30

₹32.49b

Market Cap '30

107.62m

No. shares '30

₹301.87

Share Price '30

₹301.87 Share Price '30

Discounted to 2025 @ 12.73% p.a.

₹165.83

Fair Value '25